Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | 3.04M | $4.0M | 6.53% | +128.4K | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 213.4K | -- | 0.46% | -19.1K | 2026-06-30 |
| BlackRock, Inc. | 154.4K | -- | 0.33% | -- | 2026-06-30 |
| MARSHALL WACE, LLP | 136.0K | -- | 0.29% | +110.7K | 2026-06-30 |
| BANK OF MONTREAL /CAN/ | 77.9K | -- | 0.17% | +8.0K | 2026-06-30 |
| Allianz Asset Management GmbH | 35.0K | -- | 0.08% | -- | 2026-06-30 |
| GSA CAPITAL PARTNERS LLP | 34.5K | -- | 0.07% | +24.5K | 2026-06-30 |
| Gradient Capital Advisors, LLC | 26.6K | -- | 0.06% | -- | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 25.5K | -- | 0.05% | +9.4K | 2026-06-30 |
| Federation des caisses Desjardins du Quebec | 23.3K | -- | 0.05% | -- | 2026-06-30 |
